26644 Federal Register / Vol. 82, No. 109 / Thursday, June 8, 2017 / Proposed Rules 
however, based on the structural 
similarity between tolfenpyrad and PT– CA, it is anticipated that the multiresidue method protocols would not be suitable for analysis of PT–CA. Contact: RD. 
9. PP 6E8450. (EPA–HQ–OPP–2016– 
0519). Interregional Research Project No. 4 (IR–4) Project Headquarters, Rutgers, The State University of New Jersey, 500 College Road East, Suite 201W, Princeton, NJ 08540, requests to establish tolerances in 40 CFR part 180.614 for residues of the bactericide, Kasugamycin, (3–O-[2-amino-4- [(carboxyimino-methyl)amino]-2,3,4,6- tetradeoxy-a-D-arabino-hexopyranosyl]- D-chiro-inositol) in or on Fruit, stone, subgroup 12–12A at 0.6 parts per million (ppm) and Walnut at 0.04 ppm. The Analytical Method, Meth-146, Revision #4 is used to measure and evaluate the chemical kasugamycin. Contact: RD. 
New Tolerance Exemptions for Non- 
Inerts (Except PIPS) 
PP 6F8520. (EPA–HQ–OPP–2017– 
0080). Monsanto Company, 1300 I (Eye) St. NW., Suite 450 East, Washington, DC 20005, requests to establish an exemption from the requirement of a tolerance in 40 CFR part 180 for residues of the plant growth regulator LCO SP104: D-Glucose,O–2-deoxy-2- [[(11Z)-1-oxo-11-octadecen-1-yl]amino]- b-D-glucopyranosyl-(1→4)-O–2- 
(acetylamino)-2-deoxy-b-D- glucopyranosyl-(1→4)-O–2- (acetylamino)-2-deoxy-b-D- glucopyranosyl-(1→4)-O–2- (acetylamino)- 2-deoxy-b-D- glucopyranosyl-(1→4)-2-(acetylamino)- 2-deoxy- in or on raw agricultural commodities and processed foods. The petitioner believes no analytical method is needed because analytical methods normally utilized for detection of compounds in crop plants are incapable of quantifying the negligible levels of LCO SP104 that are predicted to be presented in raw or processed agricultural commodities. Even in the unlikely event that dietary exposure does occur associated with the requested uses, the demonstrated favorable toxicological profile for LCO SP104 does not present a potential hazard for humans or the environment. Contact: BPPD. 
New Tolerance Exemptions for PIPS 
1. PP 6F8541. (EPA–HQ–OPP–2017– 
0113). Bayer CropScience LP, 2 T.W. 
Alexander Dr., Research Triangle Park, NC 27709, requests to establish an exemption from the requirement of a tolerance in 40 CFR part 174 for residues of the plant-incorporated protectant (PIP) Bacillus thuringiensis Cry14Ab-1 protein in or on soybean. The petitioner believes no analytical method is needed because this petition is for a temporary exemption from the requirement of a tolerance without numerical limitation; thus, an analytical method should not be required. Contact: BPPD. 
2. PP IN–11022 (EPA–HQ–OPP–2017– 
0115). Bayer CropScience LP, 2 T.W. Alexander Dr., Research Triangle Park, NC 27709, requests to establish an exemption from the requirement of a tolerance in 40 CFR part 174 for residues of the plant-incorporated protectant (PIP) inert ingredient 4- hydroxyphenyl pyruvate deoxygenase (HPPD–4) in or on all food commodities. The petitioner believes no analytical method is needed because this petition is for a temporary exemption from the requirement of a tolerance without numerical limitation; thus, an analytical method should not be required. Contact: BPPD. 
Authority: 21 U.S.C. 346a. 
Dated: April 27, 2017. 
Delores Barber, 
Director, Information Technology and 
Resources Management Division, Office of Pesticide Programs. 
[FR Doc. 2017–11927 Filed 6–7–17; 8:45 am] 
BILLING CODE 6560–50–P 
ENVIRONMENTAL PROTECTION 
AGENCY 
40 CFR Part 721 
[EPA–HQ–OPPT–2016–0207; FRL–9959–37] 
RIN 2070–AB27 
Significant New Use Rule on Certain 
Chemical Substances 
AGENCY : Environmental Protection 
Agency (EPA). 
ACTION : Proposed rule. 
SUMMARY : EPA is proposing a significant 
new use rule (SNUR) under the Toxic Substances Control Act (TSCA) for one chemical substance that was the subject of a premanufacture notice (PMN). The applicable review period for the PMN submitted for this chemical substance ended prior to June 22, 2016, the date on which President Obama signed into law the Frank R. Lautenberg Chemical Safety for the 21st Century Act (which amends TSCA). This action would require persons who intend to manufacture (defined by statute to include import) or process the chemical substance for an activity that is designated as a significant new use by this proposed rule to notify EPA at least 90 days before commencing that activity. The required notification initiates EPA’s evaluation of the intended use within the applicable review period. Manufacture and processing for the significant new use is unable to commence until EPA has conducted a review of the notice, made an appropriate determination on the notice, and take such actions as are required with that determination. 
DATES : Comments must be received on 
or before July 10, 2017. 
ADDRESSES : Submit your comments, 
identified by docket identification (ID) number EPA–HQ–OPPT–2016–0207, by one of the following methods: 
•Federal eRulemaking Portal: http:// 
www.regulations.gov. Follow the online 
instructions for submitting comments. Do not submit electronically any information you consider to be Confidential Business Information (CBI) or other information whose disclosure is restricted by statute. 
•Mail: Document Control Office 
(7407M), Office of Pollution Prevention and Toxics (OPPT), Environmental Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460–0001. 
•Hand Delivery: To make special 
arrangements for hand delivery or delivery of boxed information, please follow the instructions at http://www.epa.gov/dockets/contacts.html. 
Additional instructions on 
commenting or visiting the docket, along with more information about dockets generally, is available at http:// 
www.epa.gov/dockets. 
FOR FURTHER INFORMATION CONTACT : 
For technical information contact: 
Kenneth Moss, Chemical Control Division (7405M), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460–0001; telephone number: (202) 564–9232; email address: moss.kenneth@epa.gov. 
For general information contact: The 
TSCA-Hotline, ABVI-Goodwill, 422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 554– 1404; email address: TSCA-Hotline@epa.gov. 
SUPPLEMENTARY INFORMATION : 
I. General Information 
A. Does this action apply to me? 
You may be potentially affected by 
this action if you manufacture, process, 
or use the chemical substance contained in this proposed rule. The following list of North American Industrial Classification System (NAICS) codes is not intended to be exhaustive, but rather provides a guide to help readers 
VerDate Sep<11>2014 16:21 Jun 07, 2017 Jkt 241001 PO 00000 Frm 00040 Fmt 4702 Sfmt 4702 E:\FR\FM\08JNP1.SGM 08JNP1asabaliauskas on DSKBBXCHB2PROD with PROPOSALS26645 Federal Register / Vol. 82, No. 109 / Thursday, June 8, 2017 / Proposed Rules 
determine whether this document 
applies to them. Potentially affected entities may include: 
Manufacturers (including importers) 
or processors of the subject chemical substance (NAICS codes 325 and 324110), e.g., chemical manufacturing 
and petroleum refineries. 
This action may also affect certain 
entities through pre-existing import certification and export notification rules under TSCA. Chemical importers are subject to the TSCA section 13 (15 U.S.C. 2612) import certification requirements promulgated at 19 CFR 12.118 through 12.127 and 19 CFR 127.28. Chemical importers must certify that the shipment of the chemical substance complies with all applicable rules and orders under TSCA. Importers of chemicals subject to these SNURs must certify their compliance with the SNUR requirements. The EPA policy in support of import certification appears at 40 CFR part 707, subpart B. In addition, any persons who export or intend to export a chemical substance to a proposed or final rule are subject to the export notification provisions of TSCA section 12(b) (15 U.S.C. 2611(b)) (see § 721.20), and must comply with the export notification requirements in 40 CFR part 707, subpart D. 
B. What should I consider as I prepare 
my comments for EPA? 
1. Submitting CBI. Do not submit this 
information to EPA through regulations.gov or email. Clearly mark 
the part or all of the information that you claim to be CBI. For CBI information in a disk or CD–ROM that you mail to EPA, mark the outside of the disk or CD–ROM as CBI and then identify electronically within the disk or CD–ROM the specific information that is claimed as CBI. In addition to one complete version of the comment that includes information claimed as CBI, a copy of the comment that does not contain the information claimed as CBI must be submitted for inclusion in the public docket. Information so marked will not be disclosed except in accordance with procedures set forth in 40 CFR part 2. 
2. Tips for preparing your comments. 
When preparing and submitting your comments, see the commenting tips at http://www.epa.gov/dockets/ comments.html. 
II. Background A. What action is the Agency taking? 
EPA is proposing this SNUR under 
TSCA section 5(a)(2) for the chemical 
substance that was the subject of PMN P–11–482. This SNUR would require persons who intend to manufacture or 
process this chemical substance for an activity that is designated as a significant new use to notify EPA at least 90 days before commencing that activity. In accordance with the procedures at § 721.160(c)(3)(i), in the Federal Register publication of November 17, 2016 (81 FR 81250) (FRL– 9953–41) EPA issued a direct final SNUR on this chemical substance, which is the subject of a PMN. EPA received a notice of intent to submit adverse comments on this SNUR. Therefore, as required by § 721.160(c)(3)(ii), EPA withdrew the direct final SNURs in the Federal Register of January 19, 2017 (82 FR 
6277) (FRL–9958–20), and is now issuing this proposed rule on the chemical substance. The records for the direct final SNUR on the chemical substance were established as docket EPA–HQ–OPPT–2016–0207. Those records include information considered by the Agency in developing the direct final rule. While notices of intent to submit adverse comments were received during the direct final rule phase, only one substantive comment was submitted. The commenter noted a discrepancy between requirements in the consent order and SNUR. While the consent order allows limited surface water releases from the manufacturing process, the direct final SNUR designated as a significant new use any purposeful or predictable releases to surface waters. To make the SNUR consistent with consent order requirements, in this proposed SNUR EPA has designated as a significant new use any predictable or purposeful releases to water from manufacturing, processing, or use other than the water releases described in the PMN for the manufacturing process of P–11–482. EPA awaits further comment during the open comment period for this proposed rule. 
B. What is the Agency’s authority for 
taking this action? 
Section 5(a)(2) of TSCA (15 U.S.C. 
2604(a)(2)) authorizes EPA to determine that a use of a chemical substance is a ‘‘significant new use.’’ EPA must make this determination by rule after considering all relevant factors, including the four bulleted TSCA section 5(a)(2) factors listed in Unit III. Once EPA determines that a use of a chemical substance is a significant new use, TSCA section 5(a)(1)(B) requires 
persons to submit a significant new use notice (SNUN) to EPA at least 90 days before they manufacture or process the chemical substance for that use (15 U.S.C. 2604(a)(1)(B)(i)). TSCA furthermore prohibits such manufacturing or processing from commencing until EPA has conducted a review of the notice, made an appropriate determination on the notice, and taken such actions as are required in association with that determination (15 U.S.C. 2604(a)(1)(B)(ii)). As described in Unit V., the general SNUR provisions are found at 40 CFR part 721, subpart A. 
C. Applicability of General Provisions 
General provisions for SNURs appear 
in 40 CFR part 721, subpart A. These 
provisions describe persons subject to the rule, recordkeeping requirements, exemptions to reporting requirements, and applicability of the rule to uses occurring before the effective date of the final rule. Provisions relating to user fees appear at 40 CFR part 700. According to § 721.1(c), persons subject to these SNURs must comply with the same SNUN requirements and EPA regulatory procedures as submitters of PMNs under TSCA section 5(a)(1)(A). In particular, these requirements include the information submission requirements of TSCA section 5(b) and 5(d)(1), the exemptions authorized by TSCA section 5(h)(1), (h)(2), (h)(3), and (h)(5), and the regulations at 40 CFR part 720. Once EPA receives a SNUN, EPA must either determine that the significant new use is not likely to present an unreasonable risk of injury or take such regulatory action as is associated with an alternative determination before the manufacture or processing for the significant new use can commence. If EPA determines that the significant new use is not likely to present an unreasonable risk, EPA is required under TSCA section 5(g) to make public, and submit for publication in the Federal Register, a statement of 
EPA’s findings. 
III. Significant New Use Determination 
Section 5(a)(2) of TSCA states that 
EPA’s determination that a use of a 
chemical substance is a significant new use must be made after consideration of all relevant factors, including: 
•The projected volume of 
manufacturing and processing of a chemical substance. 
•The extent to which a use changes 
the type or form of exposure of human beings or the environment to a chemical substance. 
•The extent to which a use increases 
the magnitude and duration of exposure of human beings or the environment to a chemical substance. 
•The reasonably anticipated manner 
and methods of manufacturing, 
VerDate Sep<11>2014 16:21 Jun 07, 2017 Jkt 241001 PO 00000 Frm 00041 Fmt 4702 Sfmt 4702 E:\FR\FM\08JNP1.SGM 08JNP1asabaliauskas on DSKBBXCHB2PROD with PROPOSALS26646 Federal Register / Vol. 82, No. 109 / Thursday, June 8, 2017 / Proposed Rules 
processing, distribution in commerce, 
and disposal of a chemical substance. 
In addition to these factors 
enumerated in TSCA section 5(a)(2), the statute authorized EPA to consider any other relevant factors. 
To determine what would constitute a 
significant new use for the chemical substances that are the subject of these SNURs, EPA considered relevant information about the toxicity of the chemical substances, likely human exposures and environmental releases associated with possible uses, and the four bulleted TSCA section 5(a)(2) factors listed in this unit. 
IV. Substances Subject to This Proposed 
Rule 
EPA is proposing significant new use 
and recordkeeping requirements for one chemical substance in 40 CFR part 721, subpart E. In this unit, EPA provides the following information for the chemical substance: 
•PMN number. 
•Chemical name (generic name, if 
the specific name is claimed as CBI). 
•Chemical Abstracts Service (CAS) 
Registry number (assigned for non- confidential chemical identities). 
•Public comments and EPA’s 
response to comments on the direct final SNURs. 
•Basis for the TSCA non-section 5(e) 
SNURs (i.e., SNURs without TSCA 
section 5(e) consent orders). 
•Tests recommended by EPA to 
provide sufficient information to evaluate the chemical substance (see Unit VII. for more information). 
•CFR citation assigned in the 
regulatory text section of this proposed rule. 
The regulatory text section of this 
proposed rule specifies the activities designated as significant new uses. Certain new uses, including production volume limits (i.e., limits on 
manufacture volume) and other uses designated in this proposed rule, may be claimed as CBI. 
PMN Number P–11–482 
Chemical name: Bimodal mixture 
consisting of multi-walled carbon 
nanotubes and other classes of carbon nanotubes (generic). 
CAS number: Claimed confidential. 
Basis for action: The PMN states that 
the generic use of the PMN substance 
will be as a specialty additive. Based on test data on analogous respirable, poorly soluble particulates and nanocarbon materials, EPA identified concerns for pulmonary toxicity and oncogenicity. Based on test data for other nanocarbon materials EPA identified concerns for environmental toxicity. The Order was issued under TSCA sections 5(e)(1)(A)(i) 
and 5(e)(1)(A)(ii)(I), based on a finding that the substance may present an unreasonable risk of injury to human health and the environment. To protect against these risks, the consent order requires: 
1. Use of personal protective 
equipment involving impervious gloves and protective clothing (where there is a potential for dermal exposures) and a National Institute for Occupational Safety and Health (NIOSH)-certified air purifying, tight-fitting full-face respirator equipped with N–100, P–100, or R–100 cartridges, or power air purifying particulate respirator with an Assigned Protection Factor (APF) of at 
least 50 (where there is a potential for inhalation exposures). 
2. Submission of a dustiness test 
within six months of notice of commencement of manufacture (NOC). 
3. Submission of certain physical 
chemical properties data within the time limits specified in the consent order. 
4. Processing and use of the PMN 
substance only for the use specified in the consent order, including no application method that generates a vapor, mist or aerosol unless the application method occurs in an enclosed process. 
5. No predictable or purposeful 
releases to water from manufacturing, processing, or use other than the water releases described in the PMN for the manufacturing process of P–11–482 and disposal of the PMN substance only by landfill or incineration. 
The SNUR would designate as a 
‘‘significant new use’’ the absence of these protective measures. 
Recommended testing: EPA has 
determined that the development of data on certain physical-chemical properties, as well as certain human health and environmental toxicity testing would help characterize possible effects of the substance. The submitter has agreed to provide a dustiness test (European Standard EU 15051) by six months from commencement of manufacture. In addition, the submitter has agreed to provide certain physical chemical property testing as required in the consent order after the commencement of manufacture. 
Although the order does not require a 
90-day inhalation toxicity test (OPPTS Test Guideline 870.3465 or Organisation for Economic Co-operation and Development (OECD) Test Guideline 413) in rats with a post-exposure observation period of up to 9 months (including BALF analysis, a determination of cardiovascular toxicity (clinically-based blood/plasma protein analyses), and histopathology of the 
heart), a two-year inhalation bioassay (OPPTS Test Guideline 870.4200), a daphnid chronic toxicity test (OPPTS Test Guideline 850.1300), a fish early life stage toxicity test (OPPTS Test Guideline 850.1400), or an algal toxicity test (OCSPP Test Guideline 850.4500), the Order’s restrictions on manufacture, processing, distribution in commerce, and disposal will remain in effect until the Order is modified or revoked by EPA based on submission of this or other relevant information. 
CFR citation: 40 CFR 721.10927. 
V. Rationale and Objectives of the Proposed Rule 
A. Rationale 
During review of the PMN submitted 
for the chemical substance that is 
subject to this SNUR, EPA determined that one or more of the criteria of concern established at § 721.170 were met. For additional discussion on this chemical substance, see Units II. and IV. of this proposed rule. 
B. Objectives 
EPA is proposing this SNUR for 
specific chemical substance which have 
undergone premanufacture review because the Agency wants to achieve the following objectives with regard to the significant new uses designated in this proposed rule: 
•EPA would receive notice of any 
person’s intent to manufacture or process the listed chemical substance for the described significant new use before that activity begins. 
•EPA would have an opportunity to 
review and evaluate data submitted in a SNUN before the notice submitter begins manufacturing or processing the listed chemical substance for the described significant new use. 
•EPA would be able to either 
determine that the prospective manufacture or processing is not likely to present an unreasonable risk, or to take necessary regulatory action associated with any other determination, before the described 
significant new use of the chemical substance occurs. 
Issuance of a SNUR for a chemical 
substance does not signify that the chemical substance is listed on the TSCA Chemical Substance Inventory (TSCA Inventory). Guidance on how to determine if a chemical substance is on the TSCA Inventory is available on the Internet at https://www.epa.gov/tsca- inventory. 
VerDate Sep<11>2014 16:21 Jun 07, 2017 Jkt 241001 PO 00000 Frm 00042 Fmt 4702 Sfmt 4702 E:\FR\FM\08JNP1.SGM 08JNP1asabaliauskas on DSKBBXCHB2PROD with PROPOSALS26647 Federal Register / Vol. 82, No. 109 / Thursday, June 8, 2017 / Proposed Rules 
VI. Applicability of the Proposed Rule 
to Uses Occurring Before the Effective Date of the Final Rule 
To establish a significant new use, 
EPA must determine that the use is not ongoing. The chemical substance subject to this proposed rule have undergone premanufacture review. In cases where EPA has not received a notice of commencement (NOC) and the chemical substance has not been added to the TSCA Inventory, no person may commence such activities without first submitting a PMN. Therefore, for chemical substances for which an NOC has not been submitted EPA concludes that the designated significant new uses are not ongoing. 
When the chemical substance 
identified in this proposed rule is added to the TSCA Inventory, EPA recognizes that, before the rule is effective, other persons might engage in a use that has been identified as a significant new use. The identity of the chemical substance subject to this proposed rule has been claimed as confidential and EPA has received no post-PMN bona fide submissions (per §§ 720.25 and 721.11). Based on this, the Agency believes that it is highly unlikely that any of the significant new uses described in the regulatory text of this proposed rule are ongoing. 
Therefore, EPA designates February 
28, 2017 (the date of public release/web posting of this proposed rule), as the cutoff date for determining whether the new use is ongoing. This designation varies slightly from EPA’s past practice of designating the date of Federal Register publication as the date for 
making this determination. The objective of EPA’s approach has been to ensure that a person could not defeat a SNUR by initiating a significant new use before the effective date of the proposed rule. In developing this proposed rule, EPA has recognized that, given EPA’s practice of now posting rules on its Web site a week or more in advance of Federal Register publication, this objective could be thwarted even before that publication. Thus, EPA has slightly modified its approach in this rulemaking and plans to follow this modified approach in future significant new use rulemakings. 
Persons who begin commercial 
manufacture or processing of the chemical substances for a significant new use identified as of that date would have to cease any such activity upon the effective date of the final rule. To resume their activities, these persons would have to first comply with all applicable SNUR notification requirements and wait until the notice review period, including any extensions, expires. If such a person met the conditions of advance compliance under § 721.45(h), the person would be considered exempt from the requirements of the SNUR. Consult the Federal Register document of April 24, 1990 (55 FR 17376) for a more detailed discussion of the cutoff date for ongoing uses. 
VII. Development and Submission of 
Information 
EPA recognizes that TSCA section 5 
does not require developing any particular new information (e.g., generating test data) before submission of a SNUN. There is an exception: Development of test data is required where the chemical substance subject to the SNUR is also subject to a rule, order or consent agreement under TSCA section 4 (see TSCA section 5(b)(1)). 
In the absence of a TSCA section 4 
test rule covering the chemical substance, persons are required only to submit information in their possession or control and to describe any other information known to or reasonably ascertainable by them (see 40 CFR 720.50). However, upon review of PMNs and SNUNs, the Agency has the authority to require appropriate testing. Descriptions of tests are provided for informational purposes. EPA strongly encourages persons, before performing any testing, to consult with the Agency pertaining to protocol selection. To access the OCSPP test guidelines referenced in this document electronically, please go to http://www.epa.gov/ocspp and select ‘‘Test 
Guidelines for Pesticides and Toxic Substances.’’ 
The recommended tests specified in 
Unit IV. may not be the only means of addressing the potential risks of the chemical substance. However, submitting a SNUN without any test data may increase the likelihood that EPA will take action under TSCA section 5(e), particularly if satisfactory test results have not been obtained from a prior PMN or SNUN submitter. EPA recommends that potential SNUN submitters contact EPA early enough so that they will be able to conduct the appropriate tests. 
SNUN submitters should be aware 
that EPA will be better able to evaluate SNUNs and define the terms of any potentially necessary controls if the submitter provides detailed information on the following: 
•Human exposure and 
environmental release that may result from the significant new use of the chemical substances. VIII. SNUN Submissions 
According to § 721.1(c), persons 
submitting a SNUN must comply with the same notification requirements and EPA regulatory procedures as persons submitting a PMN, including submission of test data on health and environmental effects as described in 40 CFR 720.50. SNUNs must be submitted on EPA Form No. 7710–25, generated using e-PMN software, and submitted to the Agency in accordance with the procedures set forth in 40 CFR 720.40 and 721.25. E–PMN software is available electronically at https://www.epa.gov/reviewing-new-chemicals- under-toxic-substances-control-act-tsca/ how-submit-e-pmn. 
IX. Scientific Standards, Evidence, and 
Available Information 
EPA has used scientific information, 
technical procedures, measures, methods, protocols, methodologies, and models consistent with the risk assessment documents included in the public docket. These information sources supply information relevant to whether a particular use would be a significant new use, based on relevant factors including those listed under TSCA section 5(a)(2). 
The clarity and completeness of the 
data, assumptions, methods, quality assurance, and analyses employed in EPA’s decision are documented, as applicable and to the extent necessary for purposes of this proposed significant new use rule, in Unit II and in the documents noted above. EPA recognizes, based on the available information, that there is variability and uncertainty in whether any particular significant new use would actually present an unreasonable risk. For precisely this reason, it is appropriate to secure a future notice and review process for these uses, at such time as they are known more definitely. The extent to which the various information, procedures, measures, methods, protocols, methodologies or models used in EPA’s decision have been subject to independent verification or peer review is adequate to justify their use, collectively, in the record for a significant new use rule. 
X. Economic Analysis 
EPA has evaluated the potential costs 
of establishing SNUN requirements for 
potential manufacturers and processors of the chemical substances subject to this proposed rule, during the development of the direct final rule. EPA’s complete economic analysis is available in the docket under docket ID number EPA–HQ–OPPT–2016–0207. 
VerDate Sep<11>2014 16:21 Jun 07, 2017 Jkt 241001 PO 00000 Frm 00043 Fmt 4702 Sfmt 4702 E:\FR\FM\08JNP1.SGM 08JNP1asabaliauskas on DSKBBXCHB2PROD with PROPOSALS26648 Federal Register / Vol. 82, No. 109 / Thursday, June 8, 2017 / Proposed Rules 
XI. Statutory and Executive Order 
Reviews 
A. Executive Order 12866 
This proposed rule would establish 
SNUR for the chemical substance that 
was the subject of PMN. The Office of Management and Budget (OMB) has exempted these types of actions from review under Executive Order 12866, entitled ‘‘Regulatory Planning and Review’’ (58 FR 51735, October 4, 1993). 
B. Paperwork Reduction Act (PRA) 
According to PRA (44 U.S.C. 3501 et 
seq.), an agency may not conduct or 
sponsor, and a person is not required to respond to a collection of information that requires OMB approval under PRA, unless it has been approved by OMB and displays a currently valid OMB control number. The OMB control numbers for EPA’s regulations in title 40 of the CFR, after appearing in the Federal Register, are listed in 40 CFR part 9, and included on the related collection instrument or form, if applicable. 
The information collection 
requirements related to this proposed rule have already been approved by OMB pursuant to PRA under OMB control number 2070–0012 (EPA ICR No. 574). This proposed rule would not impose any burden requiring additional OMB approval. If an entity were to submit a SNUN to the Agency, the annual burden is estimated to average between 30 and 170 hours per response. This burden estimate includes the time needed to review instructions, search existing data sources, gather and maintain the data needed, and complete, review, and submit the required SNUN. 
Send any comments about the 
accuracy of the burden estimate, and any suggested methods for minimizing respondent burden, including through the use of automated collection techniques, to the Director, Collection Strategies Division, Office of Environmental Information (2822T), Environmental Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460–0001. Please remember to include the OMB control number in any correspondence, but do not submit any completed forms to this address. 
C. Regulatory Flexibility Act (RFA) 
On February 18, 2012, EPA certified 
pursuant to RFA section 605(b) (5 U.S.C. 
601 et seq.), that promulgation of a 
SNUR does not have a significant economic impact on a substantial number of small entities where the following are true: 1. A significant number of SNUNs 
would not be submitted by small entities in response to the SNUR. 
2. The SNUR submitted by any small 
entity would not cost significantly more than $8,300. 
A copy of that certification is 
available in the docket for this proposed rule. 
This proposed rule is within the 
scope of the February 18, 2012 certification. Based on the Economic Analysis discussed in Unit IX. And EPA’s experience promulgating SNURs (discussed in the certification), EPA believes that the following are true: 
•A significant number of SNUNs 
would not be submitted by small entities in response to the SNUR. 
•Submission of the SNUN would not 
cost any small entity significantly more than $8,300. 
Therefore, the promulgation of the 
SNUR would not have a significant economic impact on a substantial number of small entities. 
D. Unfunded Mandates Reform Act 
(UMRA) 
Based on EPA’s experience with 
proposing and finalizing SNURs, State, local, and Tribal governments have not been impacted by these rulemakings, and EPA does not have any reasons to believe that any State, local, or Tribal government would be impacted by this proposed rule. As such, EPA has determined that this proposed rule would not impose any enforceable duty, contain any unfunded mandate, or otherwise have any effect on small governments subject to the requirements of UMRA sections 202, 203, 204, or 205 (2 U.S.C. 1501 et seq.). 
E. Executive Order 13132 
This proposed rule would not have a 
substantial direct effect on States, on the 
relationship between the national government and the States, or on the distribution of power and responsibilities among the various levels of government, as specified in Executive Order 13132, entitled ‘‘Federalism’’ (64 FR 43255, August 10, 1999). 
F. Executive Order 13175 
This proposed rule would not have 
Tribal implications because it is not 
expected to have substantial direct effects on Indian Tribes. This proposed rule would not significantly nor uniquely affect the communities of Indian Tribal governments, nor would it involve or impose any requirements that affect Indian Tribes. Accordingly, the requirements of Executive Order 13175, entitled ‘‘Consultation and Coordination with Indian Tribal Governments’’ (65 FR 67249, November 9, 2000), do not apply to this proposed rule. 
G. Executive Order 13045 
This proposed rule is not subject to 
Executive Order 13045, entitled 
‘‘Protection of Children from Environmental Health Risks and Safety Risks’’ (62 FR 19885, April 23, 1997), because this is not an economically significant regulatory action as defined by Executive Order 12866, and this proposed rule does not address environmental health or safety risks disproportionately affecting children. 
H. Executive Order 13211 
This proposed rule is not subject to 
Executive Order 13211, entitled 
‘‘Actions Concerning Regulations That Significantly Affect Energy Supply, Distribution, or Use’’ (66 FR 28355, May 22, 2001), because this proposed rule is not expected to affect energy supply, distribution, or use and because this proposed rule is not a significant regulatory action under Executive Order 12866. 
I. National Technology Transfer and 
Advancement Act (NTTAA) 
In addition, since this proposed rule 
would not involve any technical standards, NTTAA section 12(d) (15 U.S.C. 272 note), would not apply to this proposed rule. 
J. Executive Order 12898 
This proposed rule does not entail 
special considerations of environmental 
justice related issues as delineated by Executive Order 12898, entitled ‘‘Federal Actions to Address Environmental Justice in Minority Populations and Low-Income Populations’’ (59 FR 7629, February 16, 1994). 
List of Subjects in 40 CFR Part 721 
Environmental protection, Chemicals, 
Hazardous substances, Reporting and 
recordkeeping requirements. 
Dated: February 21, 2017. 
Maria J. Doa, 
Director, Chemical Control Division, Office 
of Pollution Prevention and Toxics. 
Therefore, it is proposed that 40 CFR 
chapter I be amended as follows: 
PART 721—[AMENDED] 
■1. The authority citation for part 721 
continues to read as follows: 
Authority: 15 U.S.C. 2604, 2607, and 
2625(c). 
■2. Add § 721.10927 to subpart E to 
read as follows: 
VerDate Sep<11>2014 16:21 Jun 07, 2017 Jkt 241001 PO 00000 Frm 00044 Fmt 4702 Sfmt 4702 E:\FR\FM\08JNP1.SGM 08JNP1asabaliauskas on DSKBBXCHB2PROD with PROPOSALS26649 Federal Register / Vol. 82, No. 109 / Thursday, June 8, 2017 / Proposed Rules 
§ 721.10927 Bimodal mixture consisting of 
multi-walled carbon nanotubes and other classes of carbon nanotubes (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as a bimodal mixture consisting of multi-walled carbon nanotubes and other classes of carbon nanotubes (PMN P–11–482) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in § 721.63 
(a)(1), (a)(2)(i), (a)(2)(ii), (a)(3), (a)(4), (a)(6) (particulate), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63 (a)(1) and (a)(4), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. A National Institute for Occupational Safety and Health (NIOSH)-certified air purifying, tight-fitting full-face respirator equipped with N–100, P–100, or R–100 cartridges, or power air purifying particulate respirator with an Assigned Protection Factor (APF) of at least 50 meets the requirements of § 721.63 (a)(4). 
(ii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80 (k) and (q). A significant new use is any use involving an application method that generates a vapor, mist or aerosol. 
(iii) Disposal. Requirements as 
specified in § 721.85 (a)(1), (a)(2), (b)(1), (b)(2), (c)(1), and (c)(2). 
(iv) Release to water. Requirements as 
specified in § 721.90 (b)(1) and (c)(1). Any predictable or purposeful release of a manufacturing stream associated with any use of the substance from any site is a significant new use other than the water releases described in the manufacturing process of PMN P–11– 482. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph. 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125 (a) through (e), (i), (j), and (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. (3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725 (b)(1) apply to paragraph (a)(2)(ii) of this section. 
[FR Doc. 2017–11695 Filed 6–7–17; 8:45 am] 
BILLING CODE 6560–50–P 
DEPARTMENT OF HEALTH AND HUMAN SERVICES 
Centers for Medicare & Medicaid 
Services 
42 CFR Part 483 
[CMS–3342–P] 
RIN 0938–AT18 
Medicare and Medicaid Programs; 
Revision of Requirements for Long- Term Care Facilities: Arbitration Agreements 
AGENCY : Centers for Medicare & 
Medicaid Services (CMS), HHS. 
ACTION : Proposed rule. 
SUMMARY : This proposed rule would 
revise the requirements that Long-Term Care (LTC) facilities must meet to participate in the Medicare and Medicaid programs. Specifically, it would remove provisions prohibiting binding pre-dispute arbitration and strengthen requirements regarding the transparency of arbitration agreements in LTC facilities. This proposal would support the resident’s right to make informed choices about important aspects of his or her health care. In addition, this proposal is consistent with our approach to eliminating unnecessary burden on providers. 
DATES : To be assured consideration, 
comments must be received at one of the addresses provided below, no later than 5 p.m. on August 7, 2017. 
ADDRESSES : In commenting, please refer 
to file code CMS–3342–P. Because of staff and resource limitations, we cannot accept comments by facsimile (FAX) transmission. 
You may submit comments in one of 
four ways (please choose only one of the ways listed): 
1. Electronically. You may submit 
electronic comments on this regulation to http://www.regulations.gov. Follow 
the ‘‘Submit a comment’’ instructions. 
2. By regular mail. You may mail 
written comments to the following address ONLY: Centers for Medicare & Medicaid Services, Department of Health and Human Services, Attention: CMS–3342–P, P.O. Box 8010, Baltimore, MD 21244–1850. Please allow sufficient time for mailed 
comments to be received before the close of the comment period. 
3. By express or overnight mail. You 
may send written comments to the following address ONLY: Centers for Medicare & Medicaid Services, Department of Health and Human Services, Attention: CMS–3342–P, Mail Stop C4–26–05, 7500 Security Boulevard, Baltimore, MD 21244–1850. 
4. By hand or courier. Alternatively, 
you may deliver (by hand or courier) your written comments ONLY to the following addresses prior to the close of the comment period: 
a. For delivery in Washington, DC— 
Centers for Medicare & Medicaid Services, Department of Health and Human Services, Room 445–G, Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. 
(Because access to the interior of the 
Hubert H. Humphrey Building is not readily available to persons without Federal government identification, commenters are encouraged to leave their comments in the CMS drop slots located in the main lobby of the building. A stamp-in clock is available for persons wishing to retain a proof of filing by stamping in and retaining an extra copy of the comments being filed.) 
b. For delivery in Baltimore, MD— 
Centers for Medicare & Medicaid Services, Department of Health and Human Services, 7500 Security Boulevard, Baltimore, MD 21244–1850. 
If you intend to deliver your 
comments to the Baltimore address, call telephone number (410) 786–9994 in advance to schedule your arrival with one of our staff members. 
Comments erroneously mailed to the 
addresses indicated as appropriate for hand or courier delivery may be delayed and received after the comment period. 
For information on viewing public 
comments, see the beginning of the 
SUPPLEMENTARY INFORMATION section. 
FOR FURTHER INFORMATION CONTACT : LTC 
Regulations Team: Diane Corning, Sheila Blackstock or Lisa Parker at (410) 786–6633. 
SUPPLEMENTARY INFORMATION : 
Inspection of Public Comments: All 
comments received before the close of the comment period are available for viewing by the public, including any personally identifiable or confidential business information that is included in a comment. We post all comments received before the close of the comment period on the following Web site as soon as possible after they have been received: http://www.regulations.gov. Follow the search 
VerDate Sep<11>2014 17:20 Jun 07, 2017 Jkt 241001 PO 00000 Frm 00045 Fmt 4702 Sfmt 4702 E:\FR\FM\08JNP1.SGM 08JNP1asabaliauskas on DSKBBXCHB2PROD with PROPOSALS